In this episode of Psychedelics Weekly, the rest of the team is out or at Cannadelic, so a new voice steps up to the plate: Julian Bost, who works with the Vital team and handles the majority of our email, records his first podcast with Ph.D. candidate in Neuroscience, friend of the show, and speaker […]

The post Psychedelics Weekly – Research Explained: Ketamine and the Corticothalamic Network, Psilocybin and the Immune System, & Canalization and Plasticity appeared first on Psychedelics Today.

Previous articleRevive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch
Next articlePsychedelic Bulletin #130: Australia to Reschedule MDMA and Psilocybin; Small Pharma Reports Positive DMT Data; Journey Clinical Closes $8.5m Series A